NASDAQ · AVBP
ArriVent BioPharma, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for AVBP: Nov 9, 2026
ArriVent BioPharma, Inc. Common Stock is estimated to report earnings on 11/09/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.04. The reported EPS for the same quarter last year was $-0.83.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-1.04 | $-1.00 | $-1.09 | 3 |
| Dec 2026 | $-1.03 | $-0.98 | $-1.08 | 3 |
| Mar 2027 | $-0.93 | $-0.89 | $-0.96 | 2 |
| Jun 2027 | $-0.93 | $-0.88 | $-0.98 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
MarketBeat · Fintel · RTTNews · BNK Invest- MarketBeat · Oct 27, 12:02 AM EDTArriVent BioPharma’s ARR-217 Shows 44.8% Response Rate in Colorectal Cancer StudyDiscover the 3 Best-Performing Biotech IPO Stocks of 2024ArriVent BioPharma (NASDAQ:AVBP) presented Phase I data for ARR-217, its CDH17-targeting antibody-drug conjugate, or ADC, in heavily pretreated metastatic colorectal cancer patients during a virtual webinar following an ESM
- Fintel · Oct 26, 6:53 AM EDTArriVent BioPharma, Inc. Announces Initial Phase 1 Data for CDH17-Targeted ADC ARR-217ArriVent BioPharma, Inc. announced initial Phase 1 results for ARR-217 (MRG007), a cadherin-17-targeting antibody-drug conjugate developed in partnership with Lepu Biopharma Co., Ltd. The data, presented at the European Society for Medical Oncology Congress 2026, evaluated the ca
- RTTNews · Oct 7, 2:52 PM EDTBiotech Stocks In Focus – SXTC +536% On Sharp Move; VRXA, AVBP, SPRC On Key Developments(RTTNews) – China SXT Pharmaceuticals, Inc. (SXTC)
- BNK Invest · Sep 4, 3:50 PM EDTNoteworthy Friday Option Activity: TYRA, CLYM, AVBPAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tyra Biosciences Inc (Symbol: TYRA), where a total of 7,130 contracts have traded so far, representing approximately 713,000 underlying shares. That amounts to about 160
- BNK Invest · Jun 22, 3:39 PM EDTNotable Monday Option Activity: AVBP, SOC, HNRGAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ArriVent Biopharma Inc (Symbol: AVBP), where a total of 7,479 contracts have traded so far, representing approximately 747,900 underlying shares. That amounts to about 1
- BNK Invest · Apr 30, 3:31 PM EDTNoteworthy Thursday Option Activity: AVBP, VIAV, ASTSLooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ArriVent Biopharma Inc (Symbol: AVBP), where a total volume of 4,042 contracts has been traded thus far today, a contract volume which is representative of appro
- Zacks · Apr 15, 12:00 PM EDTAre You Looking for a Top Momentum Pick? Why ArriVent BioPharma, Inc. (AVBP) is a Great ChoiceDoes ArriVent BioPharma, Inc. (AVBP) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Zacks · Apr 13, 9:40 AM EDTAre Medical Stocks Lagging AstraZeneca (AZN) This Year?Here is how Astrazeneca (AZN) and ArriVent BioPharma, Inc. (AVBP) have performed compared to their sector so far this year.
- Zacks · Apr 6, 9:55 AM EDTWall Street Analysts Think ArriVent BioPharma, Inc. (AVBP) Could Surge 72.44%: Read This Before Placing a BetThe mean of analysts' price targets for ArriVent BioPharma, Inc. (AVBP) points to a 72.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- Zacks · Mar 26, 9:40 AM EDTAre Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?Here is how ArriVent BioPharma, Inc. (AVBP) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.
- Zacks · Mar 10, 9:55 AM EDTWall Street Analysts See a 70.37% Upside in ArriVent BioPharma, Inc. (AVBP): Can the Stock Really Move This High?The average of price targets set by Wall Street analysts indicates a potential upside of 70.4% in ArriVent BioPharma, Inc. (AVBP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock
- Zacks · Mar 10, 9:40 AM EDTIs ArriVent BioPharma, Inc. (AVBP) Stock Outpacing Its Medical Peers This Year?Here is how ArriVent BioPharma, Inc. (AVBP) and Ocugen (OCGN) have performed compared to their sector so far this year.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for ArriVent BioPharma, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.